Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open‐labeled single‐blinded randomized controlled trial
- Published on 03/10/2025
- Reading time: 1 min.
Disha Chakraborty 1, Abhishek De 2, Azhar Khan 2, Sandipan Dhar 3, Siba P. Raychaudhuri 4,5
1
Department of Dermatology and Clinical Immunology
Sacramento VA Medical Center
Mather
California
USA
2
Department of Dermatology
Calcutta National Medical College and Hospital
Kolkata
India
3
Pediatric Dermatology
Institute of Child Health Kolkata
Kolkata
India
4
Department of Dermatology and Department of Medicine/Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine
University of California Davis
Davis
CA
USA
5
Rheumatology
VA Northern California Health Care System
Sacramento
CA
USA
Abstract
Keywords: crisaborole; phosphodiesterase‐4 inhibitor; topical calcineurin inhibitor; tacrolimus; atopic dermatitis; eczema.
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Dermatology
Receive our newsletter to stay up to date with the latest news in Dermatology
